on BASTIDE (EPA:BLC)
Bastide's Financial Results for 2024-2025 Unveiled
Bastide Group has announced revenue of €491.2 million for the year 2024-2025, reflecting an 8% increase compared to the previous year after restating discontinued operations in accordance with IFRS 5. This figure exceeds the initial target of €560 million, including divested operations.
Key segments, including Respiratory and Nutrition-Perfusion-Stomatherapy-Diabetes, contributed significantly to this performance. The Respiratory segment recorded notable growth of 12.6% and the Nutrition-Perfusion segment posted an increase of 8.1%, mainly due to expansion in the Diabetes sector.
Bastide forecasts an operating margin of 9.1% for 2024-2025. Recent disposals, expected to reduce debt, underscore Bastide's ambition to achieve revenues exceeding €500 million by 2025-2026.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news